TBI

TAZOBACTAM TRANS-ENAMINE INTERMEDIATE

Find entries where: TBI

as a non-polymer is covalently linked to polymer or other heterogen groups 1 entries

Find related ligands:

Chemical Component Summary
Name	TAZOBACTAM TRANS-ENAMINE INTERMEDIATE
Identifiers	(2S,3S)-3-methyl-2-[[(E)-3-oxoprop-1-enyl]amino]-3-sulfino-4-(1,2,3-triazol-1-yl)butanoic acid
Formula	C₁₀ H₁₄ N₄ O₅ S
Molecular Weight	302.307
Type	NON-POLYMER
Isomeric SMILES	C[C@](Cn1ccnn1)([C@H](C(=O)O)N\C=C\C=O)S(=O)=O
InChI	InChI=1S/C10H14N4O5S/c1-10(20(18)19,7-14-5-4-12-13-14)8(9(16)17)11-3-2-6-15/h2-6,8,11,20H,7H2,1H3,(H,16,17)/b3-2+/t8-,10-/m0/s1
InChIKey	ANZZKUOZZHRUQC-QZWDGIGVSA-N

Chemical Details
Formal Charge	0
Atom Count	34
Chiral Atom Count	2
Bond Count	34
Aromatic Bond Count	5

Drug Info: DrugBank

DrugBank ID	DB03445
Name	Tazobactam trans-enamine intermediate
Groups	experimental
Synonyms	Tazobactam trans-enamine intermediate Tazobactam Trans-Enamine Intermediate

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Beta-lactamase SHV-1	MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASG...	unknown

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682